Segall Bryant & Hamill’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-37,455
| Closed | -$2.73M | – | 502 |
|
|
2023
Q3 | $2.73M | Buy |
37,455
+100
| +0.3% | +$7.3K | 0.03% | 386 |
|
|
2023
Q2 | $3.11M | Sell |
37,355
-226
| -0.6% | -$18.8K | 0.03% | 393 |
|
|
2023
Q1 | $2.86M | Buy |
37,581
+800
| +2% | +$61K | 0.03% | 399 |
|
|
2022
Q4 | $3.05M | Sell |
36,781
-243
| -0.7% | -$20.2K | 0.03% | 384 |
|
|
2022
Q3 | $2.95M | Hold |
37,024
| – | – | 0.04% | 387 |
|
|
2022
Q2 | $2.75M | Sell |
37,024
-226
| -0.6% | -$16.8K | 0.03% | 397 |
|
|
2022
Q1 | $3.35M | Buy |
+37,250
| New | +$3.35M | 0.03% | 390 |
|
|
2021
Q4 | – | Sell |
-19,550
| Closed | -$2.46M | – | 774 |
|
|
2021
Q3 | $2.46M | Sell |
19,550
-115
| -0.6% | -$14.4K | 0.02% | 442 |
|
|
2021
Q2 | $2.67M | Buy |
19,665
+17,727
| +915% | +$2.41M | 0.03% | 435 |
|
|
2021
Q1 | $263K | Hold |
1,938
| – | – | ﹤0.01% | 748 |
|
|
2020
Q4 | $272K | Hold |
1,938
| – | – | ﹤0.01% | 664 |
|
|
2020
Q3 | $216K | Sell |
1,938
-75
| -4% | -$8.36K | ﹤0.01% | 668 |
|
|
2020
Q2 | $225K | Buy |
+2,013
| New | +$225K | ﹤0.01% | 733 |
|
|
2016
Q2 | – | Sell |
-51,223
| Closed | -$2.65M | – | 564 |
|
|
2016
Q1 | $2.65M | Hold |
51,223
| – | – | 0.07% | 267 |
|
|
2015
Q4 | $3.6M | Hold |
51,223
| – | – | 0.09% | 249 |
|
|
2015
Q3 | $3.19M | Buy |
+51,223
| New | +$3.19M | 0.08% | 260 |
|